Accenture Chief Executive Officer (CEO) Julie Sweet has disclosed a health update in an internal mail to employees. The CEO has been diagnosed with early-stage breast cancer, with treatment expected ...

Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare insight into how executives disclose their life-altering health news.

Today, Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer.

The people who know how to communicate, and find that sweet spot, create a way to make the whole scenario a win. Zach and Julie Ertz appreciate that their longstanding relationship is the balance ...

Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...